Article content

Top News Stories For November 13 2017

The day’s top news stories from stocks on the GuerillaStockTrading watch list.

Apple Inc. (AAPL)

TASER International, Inc. (AAXN)

Abbott Laboratories (ABT)

Acacia Communications, Inc. (ACIA)

AECOM (ACM)

Amazon.com, Inc. (AMZN)

BioDelivery Sciences International, Inc. (BDSI)

Citigroup Inc. (C)

Chipotle Mexican Grill, Inc. (CMG)

Credit Suisse Group (CS)

Delta Air Lines, Inc. (DAL)

Deciphera Pharmaceuticals, Inc. (DCPH)

Walt Disney Company (The) (DIS)

Exelixis, Inc. (EXEL)

Facebook, Inc. (FB)

Global Blood Therapeutics, Inc. (GBT)

Gilead Sciences, Inc. (GILD)

Glu Mobile Inc. (GLUU)

Alphabet Inc. (GOOGL)

Goldman Sachs Group, Inc. (The) (GS)

Granite Construction Incorporated (GVA)

Huntington Ingalls Industries, Inc. (HII)

IAC/InterActiveCorp (IAC)

International Business Machines Corporation (IBM)

Internap Corporation (INAP)

Liberty Global PLC (LBTYA)

Microchip Technology Incorporated (MCHP)

The Madison Square Garden Company (MSG)

Newfield Exploration Company (NFX)

NVIDIA Corporation (NVDA)

Novartis AG (NVS)

  • (11/12) Novartis posts eye drug data amid play for Eylea’s turfopens in a new window – Novartis’s (NOVN.S) bid to move in on Bayer’s (BAYGn.DE) and Regeneron’s (REGN.O) eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker’s new RTH258 drug showed less disease activity than those on its rivals’ drug Eylea. Active disease was observed in 23.5 percent of RTH258 patients versus 33.5 percent of Eylea patients at 16 weeks, Novartis said, of its investigational treatment for wet age-related macular degeneration (AMD), where abnormal, leaky blood vessels can cause blindness. A second, similar study found active disease in 21.9 percent of RTH258 patients versus 31.4 percent of those on Eylea for the condition affecting 20-25 million people worldwide.
  • (11/12) Better Buy: Exelixis, Inc. vs. Novartis AGopens in a new window – Which stock wins in a head-to-head matchup between a rising biotech star and an established big pharma leader?

Overstock.com, Inc. (OSTK)

Smart Global Holdings Inc (SGH)

Square, Inc. (SQ)

Switch, Inc. (SWCH)

Better than bitcoin. Technology stock set to soar 200 percent. Expert analyst that got in early on Alibaba recommends buying this ASAP. Guerilla stock trading dot com

Vipshop Holdings Limited (VIPS)

Vulcan Materials Company (VMC)

Vistra Energy Corp. (VST)

  • (11/13) Vistra Energy Corp. – Value Analysis (NYSE:VST) : November 13, 2017opens in a new window – Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Vistra Energy Corp. a score of 67. Our analysis is based on comparing Vistra Energy Corp. with the following peers – Northland Power Inc., NextEra Energy Partners LP, NRG Yield, Inc. Class C and Pampa Energia SA (NPIFF-US, NEP-US, NYLD-US and PAMP-AR). Investment Outlook Vistra Energy Corp. … Read more (Read more…)

Weibo Corporation (WB)

Wipro Limited (WIT)

SPDR S&P Biotech (XBI)

DENTSPLY SIRONA Inc. (XRAY)

ZAGG Inc (ZAGG)

Zions Bancorporation (ZION)

Better than bitcoin. Technology stock set to soar 200 percent. Expert analyst that got in early on Alibaba recommends buying this ASAP. Guerilla stock trading dot com

Sofi AI Market Sentiment Gauge


SOFI artificial intelligence market gauge

Picture of SOFI artificial intelligence

Market is overbought.

Leave a Reply